Andrew Turitz Net Worth

The estimated Net Worth of Andrew Turitz is at least 4.99 百万$ dollars as of 4 September 2024. Mr. Turitz owns over 20,773 units of Teladoc Health Inc stock worth over 151,643$ and over the last 7 years he sold TDOC stock worth over 4,838,609$. In addition, he makes 0$ as Senior Vice President of Business Development at Teladoc Health Inc.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Mr. Turitz TDOC stock SEC Form 4 insiders trading

Andrew has made over 35 trades of the Teladoc Health Inc stock since 2018, according to the Form 4 filled with the SEC. Most recently he sold 20,773 units of TDOC stock worth 150,812$ on 4 September 2024.

The largest trade he's ever made was selling 36,210 units of Teladoc Health Inc stock on 2 March 2018 worth over 1,462,522$. On average, Andrew trades about 6,456 units every 57 days since 2018. As of 4 September 2024 he still owns at least 20,773 units of Teladoc Health Inc stock.

You can see the complete history of Mr. Turitz stock trades at the bottom of the page.

Andrew Turitz biography

Andrew Turitz serves as Senior Vice President of Business Development of the Company since January 2015. He is responsible for identifying, evaluating and executing growth opportunities for Teladoc Health through partnerships, acquisitions, joint ventures and other third-party relationships. From 2012 through 2015, Mr. Turitz served as Managing Director of Healthagen, a division of Aetna’s health and technology services unit, after serving as Managing Director of Blue Cross Blue Shield Ventures. Mr. Turitz has nearly 15 years of experience in healthcare transactions, including the management of all phases of acquisitions, investments and partnerships?—?from analysis, diligence and transaction structuring to product integration, go-to-market strategies and operational implementation. Mr. Turitz has advised on mergers and acquisitions transactions for Fortune 500 companies, and led investments in and served on the board of directors for venture-backed companies. He is also an entrepreneur that has launched or joined numerous early-stage businesses. Mr. Turitz holds a B.A. from Stanford University and a M.B.A. from the Kellogg School of Management at Northwestern University.

How old is Andrew Turitz?

Andrew Turitz is 47, he's been the Senior Vice President of Business Development of Teladoc Health Inc since 2015. There are 20 older and 2 younger executives at Teladoc Health Inc. The oldest executive at Teladoc Health Inc is David Shedlarz, 71, who is the Independent Director.

What's Andrew Turitz's mailing address?

Andrew's mailing address filed with the SEC is C/O TELADOC HEALTH, INC.,, 2 MANHATTANVILLE ROAD, SUITE 203, PURCHASE, NY, 10577.

Insiders trading at Teladoc Health Inc

Over the last 9 years, insiders at Teladoc Health Inc have traded over 190,385,368$ worth of Teladoc Health Inc stock and bought 50,333 units worth 544,816$ . The most active insiders traders include Hemant Taneja、Glen Tullman、Jason N Gorevic. On average, Teladoc Health Inc executives and independent directors trade stock every 6 days with the average trade being worth of 111,413$. The most recent stock trade was executed by Andrew Turitz on 4 September 2024, trading 20,773 units of TDOC stock currently worth 150,812$.

What does Teladoc Health Inc do?

Teladoc Health empowers all people everywhere to live their healthiest lives by transforming the healthcare experience. As the world leader in whole-person virtual care, Teladoc Health uses proprietary health signals and personalized interactions to drive better health outcomes across the full continuum of care, at every stage in a person’s health journey. Ranked best in KLAS for Virtual Care Platforms in 2020, Teladoc Health leverages more than a decade of expertise and data-driven insights to meet the growing virtual care needs of consumers and healthcare professionals.

Complete history of Mr. Turitz stock trades at Teladoc Health Inc

Teladoc Health Inc executives and stock owners

Teladoc Health Inc executives and other stock owners filed with the SEC include:

• Jason Gorevic,
  Chief Executive Officer, Director
• David Sides,
  Chief Operating Officer
• Mala Murthy,
  Chief Financial Officer
• Lewis Levy,
  Chief Medical Officer
• Stephanie Verstraete,
  Chief Marketing Officer
• Adam Vandervoort,
  Chief Legal Officer and Secretary
• Jason Nathanial Gorevic,
  CEO & Director
• Claus Torp Jensen Ph.D.,
  Chief Innovation Officer
• Mala Murthy,
  Chief Financial Officer
• Adam Christian Vandervoort,
  Chief Legal Officer & Sec.
• Gabriel Cappucci,
  Senior Vice President - Finance
• David Snow,
  Independent Chairman of the Board
• David Shedlarz,
  Independent Director
• Thomas McKinley,
  Independent Director
• William Frist,
  Independent Director
• Kenneth Paulus,
  Independent Director
• Mark Smith,
  Independent Director
• Catherine Jacobson,
  Independent Director
• Andrew Turitz,
  Senior Vice President of Business Development
• Michelle Bucaria,
  Chief Human Resource Officer
• Mike Waters,
  Chief Operating Officer
• Arnnon Geshuri,
  Chief HR Officer
• Andrew Turitz,
  Sr. VP of Corp. Devel.
• Courtney Kraemer McLeod,
  Director of Communication
• Patrick Thomas Feeley C.F.A., CPA,
  VP of Investor Relations
• Richard J. Napolitano,
  Sr. VP, Chief Accounting Officer & Controller
• Dr. George Byron Brooks,
  Co-Founder
• Stephany Verstraete,
  Chief Marketing Officer & Engagement Officer
• James L. Cave,
  INTERIM CAO
• Tom Mawhinney,
  Director
• Arneek Multani,
  Director
• Iii Lp Chp,
  10% owner
• Iii Lpchp Iii Management, L...,
  
• James K Outland,
  Director
• Martin R Felsenthal,
  Director
• Michael Goldstein,
  Director
• Michael H. King,
  Chief Sales Officer
• Peter N. Nieves,
  EVP and CRO
• Capital Management Vi, L.L....,
  
• Helen Darling,
  Director
• Iii Management, L.L.C. Chp,
  10% owner
• Dana G Jr. Mead,
  Director
• Arnnon Geshuri,
  CHIEF PEOPLE OFFICER
• Brian P Mcandrews,
  Director
• Mark Hirschhorn,
  Executive VP and CFO
• Peter A Mcclennen,
  President
• Venture Partners Ii, L.P.Hl...,
  
• Karen L Daniel,
  Director
• Dgf Associates, Llckpcb Dig...,
  
• Vidya Raman Tangella,
  CHIEF MEDICAL OFFICER
• Laizer Kornwasser,
  Advisor to the CEO
• Christopher Caridi,
  Chief Accounting Officer
• Richard J Napolitano,
  CHIEF ACCOUNTING OFFICER
• Yulun Wang,
  Head of Research & Development
• Hemant Taneja,
  Director
• Glen Tullman,
  Director
• Christopher Bischoff,
  
• Jason Eric Evans,
  Director
• Claus Torp Jensen,
  CHIEF INNOVATION OFFICER
• Daniel Trencher,
  CHIEF STRATEGY OFFICER
• Stephany Verstraete,
  CHIEF MARKETING OFFICER
• Michael Willem Waters,
  CHIEF OPERATING OFFICER
• Nikolaos P. Nanis,
  Chief Technology Officer
• Sandra L Fenwick,
  Director
• Charles Iii Divita,
  CHIEF EXECUTIVE OFFICER